People with type 1 diabetes risk getting kidney disease if they engage in so-called yo-yo dieting, a team of French doctors warns.The danger applies regardless of a patient's weight or other ...

Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in people with type 1 diabetes, regardless of body mass index (BMI) and other ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Robert F. Kennedy Jr., the nominee to lead the Department of Health and Human Services, made disputed claims before the ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

Several years ago, a little-known drug named Ozempic—previously used only to treat diabetes—emerged as a promising new drug ...

A class of drugs designed to fight diabetes and weight loss can help with a host of other problems, but also carry some side ...

A 2022 study found that controlling weight, blood pressure, blood sugar, and cholesterol levels can increase the life expectancy of someone with type 2 diabetes by reducing their risk of complications ...

Weight loss drugs like Ozempic and Wegovy have been tied in a large, national study to a drop in the risk of developing dozens of health conditions. But the semaglutide-like drugs also appear to ...

The S&P 500's concentration and Nasdaq 100's valuation levels are reminiscent of past bubbles, raising skepticism about current market conditions. Despite positive earnings, especially from major ...

specifically in reducing risk of cognitive decline. It is becoming clear that the benefits of these medications go beyond weight loss and diabetes control. And, of course, safety is important as ...